Premium
Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation
Author(s) -
Habbab Louay M.,
Chu F. Victor
Publication year - 2016
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.12700
Subject(s) - amiodarone , medicine , atrial fibrillation , cardiology , cardiac surgery , drug , antiarrhythmic agent , anesthesia , pharmacology , heart disease
Despite probably being the most effective prophylactic drug for postoperative atrial fibrillation (POAF), amiodarone is reserved as a second‐line agent because of its potential systemic side effects. Herein, we review the available experimental and clinical trials examining the effectiveness of intrapericardial (IPC) amiodarone administration in preventing POAF which, if confirmed by future studies, can have a significant impact on cardiac surgery practice. doi: 10.1111/jocs.12700 (J Card Surg 2016;31:253–258)